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Summary
The virulence of Salmonella is linked to its invasive capacity and suppression of adaptive 
immunity. This does not explain, however, the rapid dissemination of the pathogen after breaching 
the gut. Here we showed that early in infection, S. Typhimurium suppressed degranulation of local 
mast cells (MCs), resulting in limited neutrophil recruitment and restricted outflow of vascular 
contents into infection sites, thus facilitating bacterial spread. MC suppression was mediated by 
the Salmonella phosphatase (SptP), which shares structural homology with Yersinia YopH. SptP 
functioned by dephosphorylating the vesicle fusion protein N-ethylmalemide-sensitive factor 
(NSF) and by blocking phosphorylation of Syk. Without SptP, orally challenged S. Typhimurium 
failed to suppress MC degranulation and exhibited limited colonization of the mesenteric lymph 
nodes. Administration of SptP to sites of Escherichia coli infection markedly enhanced its 
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virulence. Thus, SptP-mediated inactivation of local MCs is a powerful mechanism utilized by S. 
Typhimurium to impede early innate immunity.
Introduction
The bacterial pathogen Salmonella enterica serovar Typhimurium (S. Typhimurium) is a 
leading cause of food-related deaths, particularly among immunocompromised individuals 
(Mead et al., 1999; Santos et al., 2009). S. Typhimurium virulence has been associated with 
the ability to evade and suppress the host immune system. Some of the earliest studies 
investigating the pathogenesis of S. Typhimurium highlighted its remarkable capacity to 
invade and persist intracellularly within gut epithelial cells and neighboring macrophages 
(Haraga et al., 2008), where it can replicate while avoiding immune cells and antimicrobial 
agents. Invasion and intracellular persistence are mediated by a variety of effector proteins 
encoded in S. Typhimurium pathogenicity islands 1 and 2 (SPI-1 and SPI-2); the majority of 
these are exported out of the bacterial cell by the well-characterized type III secretion 
system (T3SS) (Galan, 2001). One such effector is SptP, an effector protein that reverses 
cytoskeletal changes associated with S. Typhimurium entry into host cells to a pre-invasion 
state (Fu and Galan, 1999).
More recently, S. Typhimurium has been found to directly suppress host adaptive immune 
responses by impeding the actions of specific immune cells; for example, S. Typhimurium 
induces antigen-presenting cells to adopt distinct migratory paths (Cheminay et al., 2005; 
Hornef et al., 2002; McLaughlin et al., 2009) and restricts T cell proliferation and activation 
to limited regions of the body following infection (van der Velden et al., 2005; van der 
Velden et al., 2008). Other studies have pointed to a more global mechanism for the 
suppression of adaptive immune responses that involves targeting the draining lymph node, 
which is the epicenter of the adaptive immune response (St John and Abraham, 2009). S. 
Typhimurium has been shown to target and disrupt the architecture of lymph nodes by 
altering homeostatic chemokine gradients, resulting in aberrant immune cell trafficking and 
an ineffective memory response to the pathogen.
While S. Typhimurium is able to profoundly modulate specific immune responses to 
primary and therefore subsequent infections, there is also evidence that this pathogen avoids 
or actively suppresses the more immediate and non-specific host innate immune response. 
For example, S. Typhimurium avoids recognition by Pattern Recognition Receptors (PRRs) 
such as toll-like receptor-4 (TLR4) (Gunn et al., 2000; Guo et al., 1997) by selectively 
modifying its lipopolyssacharide (LPS) structure. However, this does not explain the ability 
of S. Typhimurium to rapidly proliferate, as other bacterial components such as flagella are 
readily recognized by the host PRR repertoire. The lack of an adequate innate immune 
response to control S. Typhimurium growth and spread suggests a more profound bacteria-
mediated mechanism to delay or completely suppress non-specific host responses.
An important component of the innate immune response to bacterial pathogens is the mast 
cell (MC), a morphologically distinct type of immune cell with specialized secretory 
functions that is preferentially located in close proximity to the epithelium of the 
gastrointestinal tract and other mucosal surfaces. Given their strategic location at potential 
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sites of pathogen entry, MCs are among the first immune cells to perceive and react to 
microbial penetration of the epithelial barrier (Abraham and St John, 2010; Marshall, 2004). 
There is now a broad consensus that MCs are pivotal in initiating early innate immune 
responses to invading pathogens. Studies investigating Gram-positive and Gram-negative 
bacteria as well as viruses and fungi (St John and Abraham, 2013; Urb and Sheppard, 2012) 
have revealed that MCs promote the early clearance of pathogens. MCs possess a large 
repertoire of receptors that recognize and respond to various microbial components. The MC 
response to microbial challenge is typically biphasic. First, rapid degranulation facilitates the 
release of pre-formed inflammatory mediators, including tumor necrosis factor (TNF), 
proteases, and histamine, that initiate the early recruitment of immune cells to sites of 
infection (St John and Abraham, 2013). This initial response is followed by de novo 
synthesis and secretion of various immune mediators several hours later. This biphasic 
response permits MCs not only to initiate but to sustain critical immune responses for 
prolonged periods of time. Because MCs are found in close proximity to the vasculature, 
many MC-derived mediators readily traffic into the bloodstream, initiate blood vessel 
dilation, and promote the extravasation of various immune cells (Dawicki and Marshall, 
2007; Suto et al., 2006). MC TNF has been implicated in the early recruitment of 
neutrophils to sites of E. coli infection and other enteric bacterial pathogens (Abraham and 
St John, 2010; Malaviya et al., 1996; Urb and Sheppard, 2012). In the absence of MC-
derived TNF-mediated neutrophil influx, infected mice readily succumb to infections in 
contrast to wild-type (WT) controls (Chatterjea et al., 2005; Piliponsky et al., 2010). In 
addition, MCs have also been implicated in the early recruitment of natural killer (NK) and 
NKT cells to sites of dengue virus infection, resulting in prompt viral clearance from WT 
mice (St John et al., 2011), although the specific MC mediator responsible for this clearance 
has yet to be identified. Cumulatively, there is a large body of evidence pointing to a broad 
role for MCs in promoting early pathogen clearance via immune cell recruitment to sites of 
infection. However, to date, S. Typhimurium has proven to be an exception to this paradigm. 
Although some studies have indicated that MCs appear to contribute to S. Typhimurium 
clearance, the adoptive transfer of cultured MCs into MC-deficient mice do not significantly 
alter S. Typhimurium infection (Chatterjea et al., 2005). Furthermore, the presence of MCs 
during severe S. Typhimurium infection even appear harmful (Piliponsky et al., 2010).
Given the inconclusive role of MCs during S. Typhimurium infection, here we sought to 
more closely examine interactions between MCs and S. Typhimurium in vitro and in vivo. 
We discovered that S. Typhimurium possessed a remarkable capacity to inhibit the ability of 
MCs to mount a degranulation response to powerful stimuli such as ionomycin and IgE-
mediated antigen recognition and that this inhibition was attributable to SptP, a protein 
tyrosine phosphatase secreted by S. Typhimurium T3SS. Interestingly, SptP is structurally 
analogous to several tyrosine phosphatases present in MCs as well as mediators found in 
other pathogens, such as YopH of Yersinia pestis. We determined that SptP appeared to 
dephosphorylate at least two proteins that are critical for MC degranulation. Our studies 
reveal the distinct ability of S. Typhimurium to inactivate a key modulator of host innate 
immunity and thereby facilitate stealthy infection.
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Failure of local MCs to degranulate and rapidly recruit neutrophils following S. 
Typhimurium infection
MCs possess an apparent inability to evoke protective responses in mice following S. 
Typhimurium infection. To address this failure, we hypothesized that S. Typhimurium is 
able to inactivate MCs. In order to test this notion, we injected late log phase S. 
Typhimurium SL1433 into the peritoneal cavity of WT and MC-deficient KitW-sh/KitW-sh 
(MC-deficient) mice. We chose the peritoneum for the following reasons: (i) it is a self-
contained body site where bacterial numbers and neutrophil influx can be simultaneously 
and conveniently assessed, (ii) bacteria can directly interact with MCs, and (iii) MCs can be 
readily visualized in the peritoneal fluid in order to determine activation status by evaluating 
cell morphology. Interestingly, we observed no significant difference in the bacterial 
burdens of peritoneal lavage from WT and MC-deficient mice upon infection with S. 
Typhimurium (Figure 1A, top). Consistent with this finding, myeloperoxidase (MPO) assays 
of lavage revealed no significant difference in neutrophil influx between the two groups of 
mice (Figure 1A, bottom). In contrast, when E. coli J96 was intraperitoneally injected into 
the two mouse strains, a significant difference in bacterial clearance was observed between 
WT and MC-deficient mice (Figure 1B, top). This observation correlated with an increased 
neutrophil influx in WT mice compared to MC-deficient mice (Figure 1B, bottom). The lack 
of an appreciable difference in bacterial load between WT and MC-deficient mice is 
consistent with previous reports that found no clear protective function for MCs during S. 
Typhimurium infection (Piliponsky et al., 2010). To determine whether our observations 
could be related to differential MC activation upon contact with different pathogens, we 
investigated the morphology of MCs in the peritoneal fluid (Figure 1C, top) and mesentery 
(bottom) of both groups of mice. For comparative purposes, we also examined MCs from 
PBS-injected mice. MCs from mice challenged with E. coli J96 were not readily visible by 
toluidine blue staining, as they were extensively degranulated with an observable spray of 
isolated granules around each MC (Figure 1C, middle). In contrast, MCs from S. 
Typhimurium-challenged mice were readily detectable and fully granulated (Figure 1C, 
right) and morphologically resembled MCs from controls (Figure 1C, left). Quantification of 
fully & partially granulated MCs at both of these sites is provided in Figure 1D. These 
observations collectively suggest that, unlike their vigorous response to E. coli J96, MCs 
appear incapable of evoking a degranulation response to S. Typhimurium. Consequently, 
limited neutrophil responses and corresponding bacterial clearance were observed in S. 
Typhimuriuminfected mice.
S. Typhimurium actively suppresses degranulation of murine and human MCs
To more closely investigate the limited MC degranulation response to S. Typhimurium, we 
utilized the MC model cell line RBL-2H3 in standard in vitro β-hexosaminidase release 
assays to assess MC degranulation activity following exposure to S. Typhimurium, E. coli 
J96, or ionomycin, a potent MC secretagogue which works by triggering intracellular 
calcium flux (Gilfillan and Tkaczyk, 2006). Whereas ionomycin and E. coli J96 evoked 
significant responses, no degranulation was observed in response to S. Typhimurium or to 
PBS (Figure 2A). Compared to dose-dependent MC degranulation observed with E. coli J96 
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(Figure 2B, left), the degranulation response to S. Typhimurium was minimal (Figure 2B, 
right).
The limited MC degranulation to S. Typhimurium could potentially be attributable to the 
ability of S. Typhimurium to actively block MC degranulation or to the inability of MCs to 
evoke a response to S. Typhimurium. To test the latter possibility, we exposed MCs to live 
and heat-killed S. Typhimurium and observed that MCs failed to degranulate to either 
stimulus, indicating that the MCs were inherently unresponsive to S. Typhimurium (Figure 
2C, left). Next, to investigate whether S. Typhimurium also possesses the ability to inhibit 
MC degranulation, we pre-treated MCs with live or heat-killed S. Typhimurium and then 
exposed the cells to the potent secretagogue ionomycin. We found that in contrast to killed 
S. Typhimurium, live S. Typhimurium was able to block subsequent MC responses to 
ionomycin (Figure 2C, right), indicating that S. Typhimurium has the innate capacity to 
actively block the MC degranulation. To assess the specificity of this activity, we pre-treated 
MCs with live E. coli strain CI5 or the Gram-positive pathogen Staphylococcus aureus and 
found that neither of these bacteria were able to inhibit the MC degranulation to ionomycin 
(Figure 2D).
As these observations were made in a rodent cell line, we sought to confirm them in the 
LAD2 human MC cell line. Pre-treatment of human MCs with S. Typhimurium not only 
blocked subsequent responses to ionomycin but also to other known secretagogues, C48/80 
and complement fragment C5a (Figure 2E). This suggests that S. Typhimurium possesses 
both the ability to circumvent MC activation and but also the capacity to suppress the MC 
degranulation response to activators utilizing distinct signaling pathways, suggesting a 
multipronged inhibitory activity.
SptP suppresses MC by dephosphorylating Syk and N-ethylmalemide-sensitive factor 
(NSF)
Virulence factors associated with S. Typhimurium are typically encoded by genes located in 
one or more pathogenicity islands. Therefore, we examined S. Typhimurium null mutants 
for the two best characterized pathogenicity islands, SPI1 and SPI2, as well as a double 
mutant (SPI1&SP2) for their ability to block MC degranulation. In contrast to the SPI2 
mutant (ΔSPI2), we found that the SPI1 mutant (ΔSPI1) as well as the double SPI1&SPI2 
mutant (ΔSPI1&2) failed to block ionomycin-induced degranulation (Figure 3A). The SPI1 
T3SS translocates multiple effectors directly into host cells, many of which activate or 
impede specific cellular functions (Haraga et al., 2008). Since MC degranulation requires a 
tyrosine phosphorylation cascade (Gilfillan and Tkaczyk, 2006), we postulated that a 
possible MC suppressor was the Salmonella Protein Tyrosine Phosphatase (SptP), a known 
SPI1 effector with distinct phosphatase and GTPase activities (Kaniga et al., 1996).
To investigate the role of SptP in suppressing MC activity, we first compared the ability of 
WT S. Typhimurium and an isogenic mutant ΔsptP to prevent degranulation. Here, we used 
IgE+antigen as the MC stimulant because this well-characterized signaling pathway has 
several potential targets for phosphatase activity. We found that in the case of MCs 
pretreated with ΔsptP mutant, the degranulation response to IgE stimulation was no longer 
inhibited and was even higher than that seen with IgE stimulation (Figure 3B). One 
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possibility for the enhanced degranulation response of ΔsptP treated MCs is that the 
GTPase-activating protein (GAP) domain of SptP also has a known effect promoting 
recovery of cellular cytoskeleton after Salmonella mediated invasion (Fu and Galan, 1999). 
In the absence of reorganized cytoskeleton as is the case with ΔsptP mutant, MCs 
degranulate excessively following stimulation (Foger et al., 2011).
Next, we undertook a series of complementation studies to identify the relevant region in the 
functionally distinct domains located at either end of SptP. To distinguish the effects 
between the GTPase-activating function of the amino-terminal region and the protein 
tyrosine phosphatase function associated with the carboxy-terminal region (Fu and Galan, 
1999; Kaniga et al., 1996), we complemented ΔsptP S. Typhimurium with the plasmid 
psptPWT encoding WT sptP, psptPC481S encoding sptP with an inactive phosphatase 
domain, or psptPR209A encoding sptP with an inactive GTPase domain and compared the 
ability of the complemented strains to suppress MC degranulation (Figure 3B). 
Complementation with psptPWT or with psptPR209A but not with psptPC481S inhibited MC 
degranulation in comparison to the ΔsptP mutant. These results suggest that SptP, and 
specifically the catalytic activity of its tyrosine phosphatase domain, mediates MC 
degranulation.
To investigate if SptP has the inherent ability to suppress MC degranulation, we cloned and 
expressed SptP intracellularly in the RBL-2H3 MC cell by stably transfecting with SptP-
eGFP, resulting in SptP expression in approximately 60% of cells based on fluorescent 
activity (Figure S2). We next examined the effects of SptP expression on the MC 
degranulation response to IgE+anti-IgE in RBL-2H3 cells. We observed that RBL-2H3 MC 
cells transfected with S ptP-eGFP exhibited a significant (~60%) reduction in degranulation 
compared to the control (Figure 3C).
To facilitate trafficking of SptP into the MC cytosol via non-endocytic pathways after 
exogenous treatment of SptP, we constructed a membrane-permeant SptP by conjugating it 
to the short peptide RKKRRQRRR derived from the HIV TAT (transactivator of 
transcription) protein, which can translocate itself into the cytosol of various host cells 
(Gump and Dowdy, 2007). To observe SptP-TAT penetrance into bone marrow-derived 
mast cells (BMMCs), we employed confocal microscopy to visualize the protein within 
BMMCs. We opted to employ BMMCs here to make the point that observations made using 
the RBL-2H3 cell line were also applicable to primary MCs. We observed that SptP-TAT 
readily entered BMMCs and could even be detected in the nuclei (Figure 3D, bottom). Due 
to its superior ability to penetrate MC membranes, we predicted that SptP-TAT would 
effectively block the MC degranulation response. We observed that in contrast to controls, 
SptP-TAT significantly inhibited IgE+anti-IgE mediated degranulation in a dose-dependent 
manner (Figure 3E). We also generated a catalytically inactive form of SptP-TAT, 
SptPC481S-TAT that had been observed in cytosol and nuclei (data not shown), to 
specifically ablate the tyrosine phosphatase activity. Unlike SptP-TAT, recombinant 
SptPC481S-TAT was unable to inhibit IgE+anti-IgE-mediated BMMC degranulation (Figure 
3F), confirming that SptP inhibits degranulation using its tyrosine phosphatase activity.
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Next, we sought to localize sites of tyrosine phosphorylation in MCs during degranulation 
and determine their activation following exposure to SptP-TAT. Confocal microscopy of 
BMMCs employing probes for MC granules and phosphotyrosine revealed that tyrosine 
phosphorylation appeared to be localized primarily to empty compartments where granules 
were housed prior to activation with IgE+anti-IgE (Figure 3G, middle, arrowheads). This is 
consistent with the notion that not only is tyrosine kinase activity important in the signaling 
events leading to degranulation, but it is also important in the final stages of granule release 
(Mustelin et al., 2005). We thus hypothesized that intracellular SptP could interfere with the 
regulation of the granule secretory pathway to block MC degranulation. In SptP-TAT treated 
BMMCs (Figure 3G, right), which did not degranulate following exposure to IgE+anti-IgE, 
no tyrosine phosphorylation was observed in the granule chambers, which is consistent with 
a lack of degranulation. Notably, detectable amounts of SptP were localized to the granule 
compartments. Thus, the absence of tyrosine phosphorylation proximal to sites of granule 
discharge contributes to abrogated MC degranulation in SptP-TAT-treated MCs.
The SptP-TAT-associated absence of tyrosine phosphorylation in MCs led us to seek 
putative SptP targets in the IgE signaling pathway. Syk, a tyrosine kinase, is an important 
substrate in IgE-mediated MC degranulation (Gilfillan and Tkaczyk, 2006; Masuda and 
Schmitz, 2008), and thus we examined the effects of SptP on Syk activation following IgE 
mediated activation. SptP overexpression in transfected MCs markedly suppressed the Syk 
phosphorylation following stimulation with IgE+anti-IgE (Figure 3H, top). To further 
confirm the role of Syk, we also compared IgE-mediated Syk phosphorylation in MCs pre-
treated with WT or ΔsptP S. Typhimurium. Consistent with SptP overexpression, WT S. 
Typhimurium markedly suppressed Syk phosphorylation, whereas ΔsptP S. Typhimurium 
failed to do so. Indeed, ΔsptP S. Typhimurium appeared to enhance Syk phosphorylation, 
indicating that in the absence of SptP, Salmonella might directly activate MCs and that the 
signaling events involve Syk (Figure 3H, bottom).
We also noticed that although granules of RBL-2H3 cells were not released following 1 h 
exposure WT S. Typhimurium, they appeared to have fused with each other resulting in 
abnormally large intracellular granules (Figure 3I, middle). However, this phenotype was 
not observed in MCs exposed to ΔsptP S. Typhimurium (Figure 3I, right). A critical 
determinant of MC degranulation is NSF, a vesicle fusion protein localized to the 
cytoplasmic side of granule membrane (Benhamou and Blank, 2010; Mustelin et al., 2005). 
In the steady state, NSF is typically phosphorylated which is important for keeping MC 
granules from spontaneous intracellular fusion (Huynh et al., 2004). Upon MC activation, 
NSF became dephosphorylated promoting fusion of granule membranes to plasma 
membranes resulting in extracellular release of MC granules. We suspected that in WT S. 
Typhimurium infected MCs, NSF is prematurely dephosphorylated, resulting in granule 
fusion without extracellular release. To validate this notion, control-treated, WT, and ΔsptP 
S. Typhimurium infected MCs were stained for NSF. In all cases, NSF colocalized to the 
outer surface of MC granules (Figure 3I). Furthermore, the granules of WT S. Typhimurium 
infected MCs appeared 2–3 times the size of regular granules of control MCs and ΔsptP S. 
Typhimurium infected MCs, suggesting intergranular fusion in the former (Figure 3I). To 
determine if intergranular fusion was associated with dephosphorylation of NSF, we 
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examined phosphorylation of NSF around MC granules and found that whereas NSF 
appeared phosphorylated around MC granules of PBS or ΔsptP S. Typhimurium treated 
MCs, this was not the case in WT S. Typhiumrium treated MCs (Figure 3J, middle). 
Furthermore, when we immunoprecipitated NSF from the three groups of MCs and probed 
with anti-phosphotyrosine antibodies on a western blot, we observed that in contrast to the 
other two conditions, NSF in WT S. Typhimurium infected MCs was markedly 
dephosphorylated (Figure 3K) providing support to our notions of premature intergranular 
fusion induced by S. Typhimurium phosphatases. That SptP acts at sites downstream of Syk 
can also be inferred by the fact that WT S. Typhimurium, but not ΔsptP and 
ΔsptP(psptPC481S) blocks ionomycin induced degranulation (Figure S1), which acts 
downstream of receptor mediated MC signaling events (Gilfillan and Tkaczyk, 2006).
A homologous tyrosine phosphatase produced by Yersinia pestis blocks MC 
degranulation
We have noted that SptP shares appreciable homology with phosphatases naturally found in 
MCs to prevent excessive activation (Kaniga et al., 1996; Wang et al., 2002) (data not 
shown). Yersinia pestis is another Gram-negative pathogen that expresses a potent tyrosine 
phosphatase, YopH, which shares marked structural homology with SptP (Kaniga et al., 
1996; Stebbins, 2004). Importantly, this enzyme is also injected into host cells via T3SS 
(Cornelis, 2002). In view of the similarities in terms of structure and delivery of these 
phosphatases, we speculated that MC suppression may be an evolved virulence trait shared 
among sophisticated pathogens such as S. Typhimurium and Yersinia and hypothesized that 
YopH could also suppress MC degranulation. We exposed MCs to a WT laboratory strain of 
Yersinia pestis KIM5 and examined the subsequent ability of these MCs to mount 
degranulation to ionomycin. Y. pestis-exposed MCs exhibited a significantly inhibited 
degranulation (Figure 4A). To determine whether YopH was the specific Yersinia factor 
involved in MC suppression, we cloned and expressed this tyrosine phosphatase in 
RBL-2H3 cells. In contrast to control eGFP-transfected cells, MCs transfected with YopH-
eGFP had limited degranulation to IgE+antigen (Figure 4B). Figure 4C demonstrates the 
intracellular expression of YopH, granulation status of treated MCs, and tyrosine 
phophorylation of eGFP- and YopH-eGFP-transfected RBL-2H3 cells following exposure to 
IgE+antigen. In particular, MC degranulation seemed directly correlated with tyrosine 
phosphorylation in empty granule chambers (Figure 4C, middle, arrow heads) of IgE
+antigen activated control MCs but not in YopH expressing MCs (Figure 4C). Next, we 
cloned and expressed YopH as a fusion protein with TAT. To determine whether exogenous 
YopH-TAT would inhibit MC degranulation, we exposed IgE-sensitized MCs to increasing 
concentrations of YopH-TAT and examined their responses to antigen-induced activation. 
We observed a significant and dose-dependent suppression of the MC degranulation 
response to antigen (Figure 4D). Taken together, these observations indicate that YopH 
shares the ability of SptP to suppress degranulation and suggest that MC suppression may be 
an important virulence trait among host-adapted pathogens.
ΔsptP S. Typhimurium induces MC degranulation, neutrophil influx and bacterial clearance
To investigate the in vivo contribution of SptP to MC suppression during S. Typhimurium 
infection, we challenged the peritoneal cavities of mice with WT or ΔsptP S. Typhimurium 
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(Figure 5A) and determined that MCs isolated from the peritoneal cavities exhibited widely 
different phenotypes in terms of their granulation status. MCs exposed to WT S. 
Typhimurium remained fully granulated (Figure 5A, third column), but MCs exposed to 
ΔsptP S. Typhimurium underwent extensive degranulation (Figure 5A, fourth column). This 
degranulation in response to the ΔsptP mutant when quantitated was comparable to the 
degranulation observed with E. coli J96 (Figure 5B), which was included for comparative 
purposes. The vacant granule chambers in extensively degranulated MCs stained strongly 
for tyrosine phosphorylation (Figure 5A, fourth column, arrowhead), whereas granule 
chambers in MCs exposed to S. Typhimurium or PBS failed to exhibit tyrosine 
phosphorylation staining. We observed that the overall phosphotyrosine fluorescence in 
ΔsptP-infected MCs was markedly higher (Figure 5A, fourth column) than E. coli-infected 
MCs. This enhanced tyrosine phosphorylation was previously observed in ΔsptP-exposed 
MCs in vitro (data not shown), which also consistently exhibited higher Syk 
phosphorylation than IgE+anti-IgE positive control cells (Figure 3H, bottom). This is 
potentially due to the fact that significantly higher degranulation was observed with ΔsptP S. 
Typhimurium than with the positive degranulation control (Figure 3B). As MC 
degranulation has been closely associated with neutrophil recruitment and subsequent 
bacterial clearance, we compared neutrophil responses in the peritoneum of mice following 
4 h challenge with WT or ΔsptP S. Typhimurium. Predictably, we observed significantly 
higher neutrophil responses with ΔsptP than with WT S. Typhimurium (Figure 5C), and this 
correlated with greater clearance of ΔsptP compared to WT S. Typhimurium 24 h after 
bacterial challenge (Figure 5D), which were recovered by complemented mutant strain 
(ΔsptP(psptPWT)) (Figure S3).
S. Typhimurium utilizes SptP to inhibit MC-dependent neutrophil influx and bacterial 
clearance
Given the intrinsic ability of SptP to block MC degranulation, previous studies have not 
been able to demonstrate a specific role for MCs in combating S. Typhimurium infections in 
WT and MC-deficient mice. Indeed, when we initially compared neutrophil responses and 
bacterial clearance in WT and MC-deficient mice following intraperitoneal challenge with 
WT S. Typhimurium, we failed to notice any appreciable difference between the two strains 
of mice (Figure 1A, 1C). However, based on our subsequent findings, we sought to 
demonstrate a potential MC response to S. Typhimurium by employing our ΔsptP mutant 
strain. We compared neutrophil responses and bacterial clearance of ΔsptP S. Typhimurium 
in WT and MC-deficient mice following peritoneal challenge. Neutrophil responses to 
ΔsptP S. Typhimurium was significantly more elevated in WT mice compared to MC-
deficient mice (Figure 6A, top), and this was accompanied by better clearance of ΔsptP S. 
Typhimurium in WT mice 24 h after bacterial challenge (Figure 6A, bottom).
To demonstrate the potency of the MC suppressing activity of SptP-TAT, we co-
administered recombinant SptP-TAT i.p. with E. coli J96, which normally activates MCs, 
and examined neutrophil recruitment and bacterial clearance. Compared to E. coli J96 alone, 
E. coli J96 co-instilled with SptP-TAT evoked lower neutrophil responses, and bacterial 
clearance from the peritoneum. To verify that this weak neutrophil response was linked to 
MCs, we examined isolated peritoneal MCs and found that those from mice challenged with 
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E. coli J96 with SptP-TAT were undegranulated (Figure 6C, right column) in contrast to 
mice challenged with E. coli J96 alone (Figure 6C, middle column, quantitated in Figure 
6D). Furthermore, these undegranulated MCs exhibited a limited degree of tyrosine 
phosphorylation and appeared to have accrued detectable amounts of SptP-TAT in granule 
compartments (Figure 6C, right column).
MC-mediated neutrophil recruitment is also associated with vascular leakage of serum 
components, including complement and antibodies, that can markedly impact pathogen 
persistence in tissue sites (Kunder et al., 2011; Nakamura et al., 2009). We sought to 
examine the impact of SptP on MC-mediated vascular leakage by assessing the tissue 
penetrance of intravenously administered FITC-dextran. Figure 6E shows the whole mount 
staining of mouse ears that were intradermally injected with vehicle or SptP-TAT followed 
by E. coli J96 infection. Based on the large amount of FITC-dextran in the perivascular 
space (Figure 6E, middle), E. coli J96-injected tissue exhibited a high degree of vascular 
leakage. A high degree of MC degranulation was also observed in this tissue. In contrast, no 
vascular leakage and MC degranulation was observed in tissue injected with E. coli and S 
ptP-TAT (Figure 6E, right). A significant reduction in vascular leakage induced by SptP-
TAT following E. coli J96 infection was quantitatively measured by examining extravasated 
Evans Blue in mouse ears (Figure S4). Additional whole mount staining revealed that SptP-
TAT inhibited degranulation following exposure to E. coli J96 (Figure S5) and that this 
inhibitor could be detected in the cytosol of MCs in infected tissue (Figure S6). 
Cumulatively, these findings demonstrate that SptP is a potent suppressor of MC-mediated 
activity, and in the absence of SptP, MCs would likely play an antibacterial role during 
infection with S. Typhimurium.
MC-S. Typhimurium interactions likely occur immediately after the gut epithelium is 
breached
During natural infection, S. Typhimurium that successfully breach the gut epithelial barrier 
typically target the mesenteric lymph nodes, where they proliferate with limited interference 
from the host immune system (Mastroeni et al., 2009). However, before S. Typhimurium 
can reach the draining lymph nodes, the bacteria must circumvent an array of MCs present 
in the lamina propria of the gut epithelium. Shown in Figure S7 are sections of the caecal 
epithelium of mice challenged with PBS, WT S. Typhimurium or ΔsptP S. Typhimurium. 
Numerous fully granulated MCs were seen proximal to the epithelium in PBS or WT S. 
Typhimurium challenged mice but not in mice challenged with ΔsptP S. Typhimurium 
which are incapable of suppressing MCs. Indeed, the apparent absence of fully granulated 
MCs in the caecum of ΔsptP S. Typhimurium challenged mice was attributable to extensive 
MCs degranulation induced by the many mutant S. Typhimurium found at this site (Figure 
S7). We investigated whether these MCs in the lamina propria played a role in controlling 
bacterial numbers, thus suggesting a plausible role for S. Typhimurium-mediated MC 
suppression during natural infection. To address this question, we assessed the number of 
bacteria that reached the mesenteric lymph nodes in WT and MC-deficient mice shortly after 
oral challenge with ΔsptP S. Typhimurium, which does not suppress MCs. If gut-resident 
MCs contribute to bacterial clearance, we would expect fewer bacteria to reach the 
mesenteric nodes in MC-sufficient mice compared to their MC-deficient counterparts. W e 
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detected markedly greater numbers of bacteria in the immediate draining lymph nodes of 
MC-deficient mice 24 h after oral infection with ΔsptP S. Typhimurium compared to WT 
mice (Figure 7A). Because some recent studies have questioned the use of Kit dependent 
MC deficient mice (Benhamou and Blank, 2010; St John and Abraham, 2013; Urb and 
Sheppard, 2012), we have also included here a recently described Kit independent inducible 
model of MC deficiency, involving Cma1-cre+iDTR+ mice (Benhamou and Blank, 2010). 
Using this model, we obtained very similar findings regarding the contribution of MCs in 
the clearance of ΔsptP S. Typhimurium (Figure 7B). Additionally, we confirmed the 
contribution of the phosphatase domain of SptP by challenging WT and MC-deficient mice 
with ΔsptP(psptPC481S) S. Typhimurium (Figure 7C). To confirm that the SptP deletion was 
responsible for MC-dependent bacterial clearance, we also infected WT and MC-deficient 
mice with ΔsptP(psptPWT) S. Typhimurium (Figure 7D). Predictably, we observed that the 
bacterial burden in MC-sufficient mice was now comparable to that of MC-deficient mice. 
This result is also consistent with the data presented in Figure 1A demonstrating that the WT 
S. Typhimurium burden was comparable in MC-sufficient and MC-deficient mice. Thus, 
MCs have the potential to regulate the colonization of the mesenteric lymph nodes, which 
are among the first sites targeted by pathogens that successfully breach the gut barrier.
Discussion
In this study, we have revealed a highly effective mechanism employed by S. Typhimurium 
to elude host innate immunity involving the inactivation of MCs, immune surveillance cells 
strategically located at host-environment interfaces. We demonstrated that unlike E. coli 
J96, which provoked rapid and extensive MC degranulation, S. Typhimurium not only failed 
to elicit the MC degranulation response but also prevented MC responses to a wide array of 
potent secretagogues such as IgE+antigen, calcium ionophore and complement revealing a 
broad and powerful inhibitory activity (Figure 2, 3B). This capacity to block MC responses 
to other signals is relevant during infection because even though S. Typhimurium do not 
activate MCs per se, various endogenous danger signals or alarmins are released at infection 
sites which can potentially activate MCs (Pushparaj et al., 2009). In vivo studies in mice 
revealed that this innate capacity of S. Typhimurium to block MC degranulation markedly 
reduced neutrophil responses and limited bacterial clearance at the infection site. This is in 
sharp contrast to E. coli, which elicited extensive MC degranulation, a strong neutrophil 
response, and marked bacterial clearance from the site of infection. This capacity to elude 
early innate immune responses by inactivating peripheral MCs may explain, at least in part, 
the well-recognized ability of S. Typhimurium to avoid clearance by the innate immune 
system and to disseminate rapidly from the site of infection to distal sites such as the 
draining lymph nodes and liver (Mastroeni et al., 2009). Our observation that S. 
Typhimurium inhibited early neutrophil recruitment is not inconsistent with earlier reports 
of strong neutrophil responses following S. Typhimurium infection (Cheminay et al., 2004; 
Yang et al., 2002). In this study, we focused on a narrow window of time during the early 
stages of the infection process, but observed the development of a vigorous MC-independent 
neutrophil response at sites of infection with WT S. Typhimurium after the initial lag period 
(data not shown). Our findings imply that the initial immune response to a pathogen is an 
important determinant of infection outcome. A delayed neutrophil response at the site of S. 
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Typhimurium infection, regardless of it s intensity, may have limited protective value 
because many of the bacteria are either intracellular or have become systemic at that point.
The ability of S. Typhimurium to block MC activity could, at least in part, explain why 
others have not been able to demonstrate a protective role for MCs (Chatterjea et al., 2005). 
Much of our conclusions were based using traditional Kit mutant MC deficient mice, 
however, since this model of MC deficiency has been challenged recently (Benhamou and 
Blank, 2010; St John and Abraham, 2013; Urb and Sheppard, 2012), we sought to confirm 
our findings employing Kit independent Cma1-cre+iDTR+ mice where the MC deficiency 
was inducible. Our findings utilizing the inducible model of MC deficiency corroborated 
findings with Kit mutant mice providing further validation of our conclusions.
S. Typhimurium mediated suppression of MC degranulation was achieved through 
introduction of SptP into the MC cytosol. The suppressing actions of SptP are restricted to 
the exocytic function of MCs because MCs readily internalize S. Typhimurium upon 
contact. SptP is a SPI1 effector protein with two functional domains. The N-terminal domain 
functions during pathogen entry into host cells by deactivating Rho GTPases and reversing 
pathogen-induced cytoskeletal changes following S. Typhimurium uptake (Fu and Galan, 
1999). The second, C-terminal domain comprises a protein tyrosine phosphatase reported to 
function late in the pathogen entry process when S. Typhimurium is harbored within late 
endosomes (Humphreys et al., 2009). In these compartments, it is believed that SptP 
dephosphorylates a protein that facilitates cellular membrane fusion and protein degradation, 
enhancing intracellular S. Typhimurium replication. The tyrosine phosphatase domain of 
SptP is also thought to inactivate MAP kinase (Murli et al., 2001). Our finding that the 
tyrosine phosphatase region of SptP mediates MC inactivation represents a distinct function 
for this domain, while our work with GTPase-inactive SptP as well as YopH, which lacks a 
GTPase domain, suggests that GTPase activity is for the most part dispensable for MC 
suppression. A comparison of the primary structure of SptP with multiple tyrosine 
phosphatases found in the cytosol of MCs reveals high degree of homology (Kaniga et al., 
1996), implying multiple targets for this phosphatase. Morphological studies of MCs 
employing pTyr-specific antibody probes revealed that degranulation was closely associated 
with phosphorylation events at the cell surface as well as at intracellular sites proximal to 
cytosolic granules. Phosphorylation of these proteins at both sites did not occur in the 
presence of SptP, suggesting that SptP acted at multiple sites and on multiple targets. By 
examining S. Typhimurium infected MCs before or after activation with various 
secretagogues we have been able to identify at least two distinct substrates for SptP. 
Immunoblot analyses of S. Typhimurium-infected MCs and control MCs following IgE 
mediated activation revealed one of the intracellular targets of SptP to be Syk, which is a 
member of the Syk/Zap-70 family, and a substrate found early in the signaling cascade. 
Microscopic and immunoprecipation studies of MCs infected with WT S. Typhimurium also 
revealed that shortly after infection MC granules spontaneously coalesced forming oversized 
granules which failed to be expelled upon subsequent exposure to potent secretegogues. This 
phenomenon was not observed with ΔsptP S. Typhimurium indicating that it was an SptP 
mediated activity. We have linked this intergranular fusion to SptP mediated 
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dephophorylation of NSF, a fusion protein whose functions include preventing homotypic 
intergranular fusion (Mustelin et al., 2005; Wang et al., 2002).
Although a number MC-inactivating compounds derived from various microbes have been 
identified, including the toxic fungal metabolite gliotoxin (Cramer et al., 2006; Niide et al., 
2006), ES-62, a glycoprotein secreted by filarial nematodes (Melendez et al., 2007), FK506 
from Streptomyces tsukubaensis (Narenjkar et al., 2006), and cyclosporine A from 
Tolypocladium inflatum (Harrison et al., 2007), these do not, for the most part, appear to be 
relevant in the pathogenesis of infection. Our studies here reveal that two highly successful 
host-adapted pathogens, S. Typhimurium and Y. pestis, share a powerful mechanism to 
suppress MC degranulation, suggesting that MC inhibition is an important virulence 
determinant. MCs are one of the first immune cells encountered by these pathogens after 
they traverse the epithelial barrier. They are relatively abundant in dermal tissue, where Y. 
pestis is localized following injection by fleas, and also common in the gut epithelium below 
Peyer’s patches as well as in the lamia propria, where they can encounter S. Typhimurium 
invading through M cells or gut epithelial cells (Jones et al., 1994). Orally-administered S. 
Typhimurium that successfully breach the epithelial barrier traffic to the mesenteric lymph 
nodes, a process likely to be influenced by MC interactions. Indeed, significantly higher 
numbers of the ΔsptP mutant were present in the mesenteric nodes of MC-deficient mice 
following oral infection, implicating mucosal MCs as primary responders to S. 
Typhimurium breaching the gut epithelium.
MCs and MC-like cells are found in a wide range of animal species including less evolved 
species devoid of an adaptive immunity. In recent years it has become clear that MCs play a 
key role in modulating innate immune responses to various bacteria, parasites, viruses and 
fungi suggesting that the raison d'être for these cells is modulation of immediate and 
nonspecific immunity to microbial challenge. In view of this it is not surprising that certain 
virulent pathogens would have evolved special mechanisms to inactivate these cells to 
prevent or delay host immune responses and promote their pathogenesis.
Experimental Procedures
Bacterial strains and culture
S. Typhimurium SL1344, SL1344-derived Tn5 transposon insertion mutants in SPI1, SPI2, 
and SPI1&2 were gifts from Dr. Alejandro Aballay, Duke University. SB300, and its sptP 
deletion mutant, SB749, were gifts from Dr. Jorge E. Galán, Yale University. 
ΔsptP(psptPWT), ΔsptP(psptPC481S), and ΔsptP(psptPR209A) were generated in this study. 
Other strains used include E. coli J96 and CI5, a Gram-positive clinical isolate 
Staphylococcus aureus strain 54 (Duke University Medical Center), and a WT laboratory 
strain of conditionally virulent and naturally occurring Yersinia pestis KIM5. Bacteria were 
grown for 15 h, non-shaking, in Luria-Bertani (LB) (Gibco) broth at 37°C. 25 µg/ml 
kanamycin was added for transposon mutants, 100 µg/ml streptomycin for SB300 and 
SB749, and 100 µg/ml carbenicillin for complemented strains.
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C57BL/6 mice were purchased from the National Cancer Institute. MC-deficient Wsh mice 
(KitW-sh/KitW-sh) and their congenic littermate controls were from Jackson Laboratories. To 
induce MC depletion, eight-week-old Cma1-cre+iDTR+ (a gift from Dr. Axel Roers, 
University of Technology, Dresden) and wild-type littermates received five i.v. injections of 
100 ng DT per mouse in a week. All experiments were performed according to protocols 
approved by the Duke Division of Laboratory Animal Resources and the Duke University 
Institutional Animal Care and Use Committee.
Animal infections and CFU counts
Mice were infected i.p. with S. Typhimurium, or E. coli J96 in 100 µl sterile PBS. At 
indicated times, peritoneal lavage was performed with 5 ml sterile, ice-cold PBS. Lavage 
was analyzed for MC degranulation, neutrophil influx or CFU. Oral infection was as 
described (Barthel et al., 2003). Briefly, mice were pretreated with 20 mg streptomycin prior 
to infection with 5×107 CFU of ΔsptP or its complemented mutant S. Typhimurium. At 
various times, mice were sacrificed and mesenteric lymph nodes homogenized in 0.1% 
Triton X-100 per PBS. Lysates were plated on MacConkey agar with or without 50 µg/ml 
streptomycin and incubated overnight at 37°C for CFU.
Enzymatic assays
β-hexosaminidase assay and myeloperoxidase assay are described in the supplemental 
experimental procedures.
Microscopy
Staining of cultured BMMCs, peritoneal cells, the mesentery and ear tissue are described in 
the supplemental experimental procedures. A Nikon ECLIPSE TE200 microscope was used 
to obtain confocal images using a channel-series approach.
Statistical analysis
Results were analyzed with one-way ANOVA and Tukey’s post-test or two-way ANOVA or 
the Mann-Whitney t-test as appropriate with Prism (GraphPad) software. Differences 
between groups were considered significant at p<0.05. All error bars represent SEM.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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• Salmonella Typhimurium specifically suppresses mast cell degranulation.
• Mast cell suppression reduced neutrophil influx early in Salmonella infection.
• SptP inhibited mast cell degranulation by dephosphorylating Syk and NSF.
• Compared to WT Salmonella the SptP mutant is cleared early in infection.
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Fig 1. S. Typhimurium fails to elicit MC activation and subsequent neutrophil recruitment and 
bacterial clearance in vivo
(A, B, top) Residual bacterial counts (CFUs) in the peritoneal cavity of wild-type (WT) or 
MC-deficient mice 24 h following intraperitoneal (i.p.) infection with 5×105 CFU S. 
Typhimurium or 1×107 CFU E. coli. (A, B, bottom) Myeloperoxidase assay of peritoneal 
lavage of WT or MC-deficient mice 5 h post-infection with 1×107 CFU S. Typhimurium or 
E. coli J96 (C) Morphologic appearance of MCs in the peritoneum (top) and mesentery 
(bottom) of WT mice 3 h after i.p infection of 1×108 CFU S. Typhimurium or E. coli J96. 
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Insets represent 60X magnification of MCs in the mesentery. Images represent 3 
independent experiments. Top panels and inset scale: 20 µm. Bottom panels scale: 100 µm. 
n=4. (D) Granulated MC numbers in peritoneal lavages (top) or mesentery whole mounts 
(bottom) were quantified by counting the number of partially and fully granulated MCs/field 
(n=3–5; 5 random chosen fields). Wholly degranulated MCs could not be detected. Mean ± 
SEM, *p<0.05, **P<0.01, N.S., not significant.
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Fig 2. S. Typhimurium pretreatment actively suppresses MC degranulation to MC secretagogues
(A, B) In vitro β-hexosaminidase release assays of RBLs after 1 h exposure to S. 
Typhimurium (STm) or E. coli J96. (B) Effect of bacterial MOIs (10:1, 100:1, 1000:1) on 
MC degranulation. (C, left) β-hexosaminidase release by RBLs following 1 h exposure to 
live or heat-treated (60°C, 1 h) STm. (C, right and D) RBL degranulation to ionomycin 
after 30 min pretreatment with (C, right) live or heat-killed STm, and to (D) various 
bacteria. (E) LAD2 degranulation to ionomycin (left), C48/80 (middle), or C5a (right) after 
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30 min pretreatment with live STm or PBS (control). Mean ± SEM, *p<0.001, **p<0.01, 
***p<0.05, N.S., not significant.
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Fig 3. The protein tyrosine phosphatase domain of the SPI-1 effector, SptP, inhibits MC 
degranulation through dephosphorylating Syk and NSF
(A) MC degranulation to ionomycin after 30 min pretreatment with WT, ΔSPI1 mutant, 
ΔSPI2 or ΔSPI1&ΔSPI2 STm strains (B) Degranulation of IgE sensitized MCs to antigen 
(Ag, TNP-OVA) after 45 min pretreatment with wild-type, ΔsptP or complemented ΔsptP 
strains (ΔsptP(psptPWT), ΔsptP(psptPC481S), or ΔsptP(psptPR209A)). (C) Degranulation of 
IgE sensitized MCs expressing retrovirally transduced eGFP or SptP-eGFP to anti-IgE. (D) 
Confocal microscopy of BMMCs exposed to SptP-TAT for 4 h. MC granules were probed 
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with avidin (green) and intracellular SptP-TAT probed with anti-His6 (red). (E and F) 
Degranulation of IgE-sensitized BMMCs to anti-IgE (E) after 4 h pretreatment with 
increasing amounts of SptP-TAT (10, 1, and 0.1 µg) or (F) after 2 h pretreatment with SptP-
TAT (5 µg) or SptPC481S-TAT (5 µg). (G) Morphological appearance of IgE sensitized 
BMMCs to anti-IgE after 2 h pretreatment with vehicle or SptP-TAT (10 µg). MC granules: 
avidin (red), SptP-TAT: anti-His6 (green), and intracellular tyrosine phosphorylation sites: 
anti-phosphotyrosine (p-Tyr) (blue) antibodies. (H) Western blots of cell preparations from 
IgE-sensitized RBLs that were either stably expressing SptP-eGFP or control eGFP (top) or 
were pretreated with WT STm or ΔsptP STm for 1 h (bottom) before activation with anti-
IgE. The cell preparations from both experiments were obtained at indicated time points 
after activation with anti-IgE. Western blots were probed with α-p-Syk, α-Syk, and α-β-
actin antibodies. (I, J) Morphology of RBLs after exposure to WT or ΔsptP STm. After 1 h 
treatment, (I) cells were stained with antibodies for fluorescence microscopy. MC granules: 
α-serotonin (green), NSF: α-NSF (red) antibodies and actin: phalloidin (blue). (J, K) After 1 
h treatment, cells were treated with vanadate (100 µM) for 5 min to preserve tyrosine 
phosphorylation and (J) were stained with antibodies for fluorescence microscopy. NSF: α-
NSF (red) and intracellular tyrosine phosphorylation: α-pTyr (green) and actin: phalloidin 
(blue). (K) Lysates from RBLs were analyzed by immunoprecipitation and immunoblotting 
for phosphotyrosine and NSF. Scale bar is 20 µm. Mean ± SEM, *p<0.001, **p<0.01, 
***p<0.05. See also Figure S1 and S2.
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Fig 4. Yersinia pestis YopH suppresses MC activation
(A) Degranulation to ionomycin of RBLs pretreated for 30 min with PBS or Y. pestis KIM5. 
(B and C) RBLs were retrovirally transduced with control eGFP or YopH-eGFP before IgE
+antigen stimulation (Ag, TNP-OVA) and assaying for degranulation (B), or subjected to 
confocal microscopy (C). Granules were stained with serotonin (red) and tyrosine 
phosphorylation with anti-p-Tyr antibody (blue). (D) Degranulation to IgE+Ag (TNP-OVA) 
RBLs following exposure to increasing concentration of purified YopH-TAT. Scale bar: 10 
µm, mean ± SEM, *p<0.001, **p<0.01.
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Fig 5. Infection of mice with ΔsptP activates MCs and enhances neutrophil recruitment and 
bacterial clearance compared to WT
(A) WT, ΔsptP STm, or E. coli J96. 1×108 CFU WT, ΔsptP STm, or E. coli J96 were 
injected i.p. Peritoneal lavage was harvested 4 h later, cytospun, and stained with toluidine 
blue for bright field microscopy (top) or with α-serotonin (red) for granules, and α-
phosphotyrosine (blue) for immunofluorescence microscopy. (B) Granulated MC numbers 
in peritoneal lavages of (A) were quantified by counting partially and fully granulated MCs/
field (n=3–6; 5 random chosen fields). Wholly degranulated MCs could not be detected. (C) 
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Assays for neutrophil recruitment (MPO) and (D) bacterial clearance (CFUs) were 
performed on lavages collected 4 h and 24 h, respectively, after i.p injection of 1×106 CFU 
WT or ΔsptP STm. n=4 mice, mean ± SEM, *p<0.05, **p<0.01. Scale bar: 20 µm. See also 
Figure S3.
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Fig 6. ΔsptP S. Typhimurium evokes MC-dependent neutrophil recruitment, bacterial clearance 
and vascular leakage
Neutrophil influx (top) and bacterial counts (bottom) in WT and MC-deficient mice (A) 
following i.p. injection of 5×105 CFU ΔsptP STm, (B) SptP-TAT (100 µg/mouse) or vehicle 
followed 30 min later with 1×107 CFU E. coli. MPO assays were performed 5 h post-
infection and CFUs 24 h post-infection. (C) Morphology of MCs in the peritoneal cavities of 
control and SptP-TAT treated mice 3 h following E. coli infection. MC granules: avidin 
(red), SptP-TAT: anti-His6 (green) and sites of tyrosine phosphorylation: anti-p-Tyr 
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antibodies (blue). Scale bars: 20 µm. (D) Granulated MC numbers in peritoneal lavages of 
(C) were quantified by counting the number of partially and fully granulated MCs/field 
(n=5; 5 random chosen fields). Totally degranulated MCs could not be detected. (E) Mouse 
ears were injected intradermally with vehicle or SptP-TAT (20 µg) and injected 1 h later 
with 1×106 CFU E. coli J96 at the same site and FITC-dextran (green) i.v.1 h post-infection, 
the ears were dissected, stained with avidin (red) and anti-CD31(blue), and whole mounted 
for immunofluorescence microscopy. Mean ± SEM, *p<0.05, **p<0.01. Scale bars: 50 µm. 
See also Figure S4, S5, and S6.
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Fig 7. Intestinal MCs reduce bacterial burden in mesenteric lymph nodes following oral infection 
with ΔsptP S. Typhimurium
CFU of mesenteric lymph nodes in streptomycin-treated (A, C, D) WT or MC-deficient 
mice, (B) Cma1-cre+iDTR+ mice or WT controls after DT injections, following oral 
challenge with 5×107 CFU (A, B) ΔsptP S. Typhimurium, (C) ΔsptP(psptPC481S) and (D) 
ΔsptP(psptPWT) 24 h post-infection. *p<0.01, **p<0.05, N.S., not significant. See also 
Figure S7.
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